STOCK TITAN

Nanalysis Announces First Quarter 2025 Conference Call

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF) has scheduled its First Quarter 2025 earnings conference call for Wednesday, May 28th, 2025, at 5:00 PM ET. CEO Sean Krakiwsky and CFO Randall McRae will discuss the financial results for the quarter ended March 31, 2025. Investors can participate by dialing 1-888-510-2154 (domestic) or 437-900-0527 (international), or via webcast.

A dedicated European Q&A session will follow on Thursday, May 29th at 8:30 AM ET. The earnings call webcast will be archived for 90 days on the company's website, and a telephonic replay will be available for seven days using conference ID #00805.

Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF) ha programmato la conference call per la presentazione dei risultati del primo trimestre 2025 per mercoledì 28 maggio 2025 alle 17:00 ET. Il CEO Sean Krakiwsky e il CFO Randall McRae discuteranno i risultati finanziari del trimestre terminato il 31 marzo 2025. Gli investitori potranno partecipare chiamando il numero 1-888-510-2154 (nazionale) o 437-900-0527 (internazionale), oppure tramite webcast.

Una sessione dedicata di domande e risposte per l'Europa seguirà giovedì 29 maggio alle 8:30 ET. La registrazione della conference call sarà disponibile in archivio sul sito web della società per 90 giorni, mentre la replica telefonica sarà accessibile per sette giorni utilizzando l'ID conferenza #00805.

Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF) ha programado su llamada de conferencia para resultados del primer trimestre de 2025 para el miércoles 28 de mayo de 2025 a las 5:00 PM ET. El CEO Sean Krakiwsky y el CFO Randall McRae discutirán los resultados financieros del trimestre finalizado el 31 de marzo de 2025. Los inversores pueden participar llamando al 1-888-510-2154 (nacional) o 437-900-0527 (internacional), o a través de webcast.

Una sesión dedicada de preguntas y respuestas para Europa seguirá el jueves 29 de mayo a las 8:30 AM ET. La grabación de la llamada de resultados estará archivada durante 90 días en el sitio web de la empresa, y una repetición telefónica estará disponible durante siete días utilizando el ID de conferencia #00805.

Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF)는 2025년 5월 28일 수요일 오후 5시(동부시간)에 2025년 1분기 실적 컨퍼런스 콜을 예정하고 있습니다. CEO Sean Krakiwsky와 CFO Randall McRae가 2025년 3월 31일로 종료된 분기의 재무 결과를 발표할 예정입니다. 투자자들은 국내 전화 1-888-510-2154 또는 국제 전화 437-900-0527로 참여하거나 웹캐스트를 통해 참여할 수 있습니다.

유럽 투자자 대상 질의응답 세션2025년 5월 29일 목요일 오전 8시 30분(동부시간)에 이어서 진행됩니다. 실적 발표 콜 웹캐스트는 회사 웹사이트에 90일간 아카이브되며, 전화 재청취는 회의 ID #00805를 사용해 7일간 가능합니다.

Nanalysis Scientific Corp. (TSXV : NSCI, OTCQX : NSCIF) a programmé sa conférence téléphonique sur les résultats du premier trimestre 2025 pour le mercredi 28 mai 2025 à 17h00 ET. Le PDG Sean Krakiwsky et le directeur financier Randall McRae discuteront des résultats financiers du trimestre clos le 31 mars 2025. Les investisseurs peuvent participer en composant le 1-888-510-2154 (domestique) ou le 437-900-0527 (international), ou via le webcast.

Une session dédiée de questions-réponses pour l'Europe suivra le jeudi 29 mai à 8h30 ET. L’enregistrement du webcast de la conférence sera archivé pendant 90 jours sur le site web de la société, et une rediffusion téléphonique sera disponible pendant sept jours avec l’ID de conférence #00805.

Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF) hat seine Telefonkonferenz zur Bekanntgabe der Ergebnisse für das erste Quartal 2025 für Mittwoch, den 28. Mai 2025, um 17:00 Uhr ET angesetzt. CEO Sean Krakiwsky und CFO Randall McRae werden die Finanzergebnisse für das Quartal zum 31. März 2025 besprechen. Investoren können teilnehmen, indem sie die Nummer 1-888-510-2154 (national) oder 437-900-0527 (international) anrufen oder per Webcast teilnehmen.

Eine spezielle europäische Fragerunde folgt am Donnerstag, den 29. Mai um 8:30 Uhr ET. Die Webcast-Aufzeichnung der Telefonkonferenz wird für 90 Tage auf der Website des Unternehmens archiviert, und eine telefonische Wiederholung ist für sieben Tage mit der Konferenz-ID #00805 verfügbar.

Positive
  • None.
Negative
  • None.

Hosting Call at 5:00 pm ET on Wednesday, May 28th

European Q&A Session on Thursday, May 29th  at 8:30am ET

CALGARY, AB, May 15, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR instruments and imaging technology and services for industrial and research applications that on Wednesday, May 28th, 2025, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter ended March 31, 2025. 

Investors interested in participating in the live full year call can dial 1-888-510-2154 or 437-900-0527-from abroad. Investors can also access the call online through a listen-only webcast here: https://app.webinar.net/eXAlax953qK on the investor relations section of the Company's website
HERE.

The webcast will be archived on the Company's investor relations webpage for at least 90 days and a telephonic playback will be available for seven days after the conference call by calling 1-888-660-6345 or 289-819-1450, conference ID # 00805.

Additionally, the Company will be hosting a Q&A session for it's European investors at 8:30am ET on Thursday, May 29th which can be accessed by the following link: Join the meeting now

About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)

Nanalysis Scientific Corp. in operates two primary business segments: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz platform, which has the highest usable field on a fully featured benchtop NMR on the market.  In early 2025, the Company launched its new 60MHz instrument which is based on the successful 100MHz product line.

The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company is working to expand into new global market opportunities independently and with partners.  With its partners, the Company provides scientific equipment sales and maintenance services globally. 

In 2022 the Company was awarded a five-year, $160 million contract to provide maintenance services for passenger screening equipment in Canadian airports.  This has resulted in expansion of the Company's Security Services business.  The Company is providing airport security equipment maintenance services in each province and territory of Canada.  In addition, the Company provides commercial security equipment installation and maintenance services to a variety of customers in North America. 

Notice regarding Forward Looking Statements and Legal Disclaimer

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-first-quarter-2025-conference-call-302456542.html

SOURCE Nanalysis Scientific Corp.

FAQ

When is Nanalysis Scientific (NSCIF) Q1 2025 earnings call?

Nanalysis Scientific's Q1 2025 earnings call is scheduled for Wednesday, May 28th, 2025, at 5:00 PM Eastern Time.

How can I listen to Nanalysis Scientific's Q1 2025 earnings call?

You can listen by dialing 1-888-510-2154 (domestic) or 437-900-0527 (international), or via webcast at https://app.webinar.net/eXAlax953qK

When is Nanalysis Scientific's European Q&A session for Q1 2025?

The European Q&A session is scheduled for Thursday, May 29th, 2025, at 8:30 AM Eastern Time.

How long will Nanalysis Scientific's Q1 2025 earnings call replay be available?

The webcast will be archived for 90 days on the company's website, and a telephonic replay will be available for 7 days using conference ID #00805.
Nanalysis Sci

OTC:NSCIF

NSCIF Rankings

NSCIF Latest News

NSCIF Stock Data

23.33M
72.31M
3.98%
Scientific & Technical Instruments
Technology
Link
Canada
Calgary